Stellar Biotechnologies announced that its
management team will be presenting at the 7th Annual Biotech Showcase 2015
conference, which is being held at the Parc 55 Wyndham Hotel in San Francisco,
CA.
Details of Presentation
Date: Tuesday, January 13, 2015
Time: 2:30 p.m. PST
Room & Track: C-Mission II (4th Floor)
Stellar Biotechnologies is a recognized leader
in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), which is both an
active pharmaceutical ingredient (API) in many new immunotherapies (targeting
cancer, immune disorders, Alzheimer’s and inflammatory diseases) as well as a
finished product for measuring immune status. Stellar Biotechnologies is unique
in its proprietary methods, facilities, and KLH technology.
For more information on the company, visit
www.stellarbiotech.com
About
MissionIR
MissionIR is committed to connecting the
investment community with companies that have great potential and a strong
dedication to building shareholder value. We know our reputation is based on
the integrity of our clients and go to great lengths to ensure the companies
represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
